Radiopharm Theranostics RADX
NASDAQ RADX
$0.88 -0.07 (-7.70%)
At close: Nov 9, 2026 · 4:00 PM EST

Radiopharm Theranostics (RADX) Non-Current Assets (2024 - 2026)

Updated

Radiopharm Theranostics (RADX) reported Non-Current Assets of $271,029 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 9.2% from $298,620 a year earlier.

Analysis

Radiopharm Theranostics (RADX) Non-Current Assets (2024 - 2026) Analysis & Trends

At the end of FY2026 (ended Jun 30, 2026), Radiopharm Theranostics posted Non-Current Assets of $259,493, down 99.4% from FY2025.

  • By fiscal year, Non-Current Assets came in at $46.63 million in FY2025 (-5.2%) and $49.19 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn 82.81 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn 141.07 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn 110.20 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn 75.00 Mn
5 Novartis Ag 316.85 Bn 290.09 Bn - -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn 88.47 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn 61.69 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn 34.86 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn 159.99 Bn
10 Radiopharm Theranostics 2.70 Bn 2.62 Bn - 38.21 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 38.21 Mn
Jun 30, 2025 46.63 Mn
Dec 31, 2024 48.10 Mn
Jun 30, 2024 49.19 Mn
API Access

Radiopharm Theranostics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=RADX&period=max&api_key=YOUR_API_KEY